Cormack Scott Daniel
Insider CIK 1442675 · OGXI President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2020-05-12 | 2020-05-14 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2019-05-14 | 2019-05-15 | 7,000 | — | $0 | 7,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2018-09-20 | 2018-09-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2017-10-10 | 2017-01-12 | 4,687 | — | $0 | 9,375 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2017-10-10 | 2017-01-12 | 3,125 | — | $0 | 3,125 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | F Tax w/h | 2017-09-08 | 2017-09-12 | 1,491 | $3.09 | $4.6K | 14,810 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2017-08-01 | 2017-08-03 | 568 | — | $0 | 0 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2017-08-01 | 2017-08-03 | 1,705 | — | $0 | 0 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2017-08-01 | 2017-08-03 | 852 | — | $0 | 0 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2017-08-01 | 2017-08-03 | 284 | — | $0 | 0 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2017-08-01 | 2017-08-03 | 852 | — | $0 | 0 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2017-08-01 | 2017-08-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2017-08-01 | 2017-08-03 | 454 | — | $0 | 0 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2017-08-01 | 2017-09-12 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise | 2017-08-01 | 2017-08-03 | 3,125 | — | $0 | 16,302 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise | 2017-08-01 | 2017-08-03 | 1,590 | — | $0 | 9,685 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2017-06-12 | 2017-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2017-06-12 | 2017-06-14 | 9,375 | — | $0 | 9,375 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2017-06-12 | 2017-06-14 | 9,375 | — | $0 | 149,425 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2017-06-12 | 2017-06-14 | 5,000 | — | $0 | 89,055 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | F Tax w/h | 2017-06-12 | 2017-06-14 | 4,472 | $0.36 | $1.6K | 144,953 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2017-01-10 | 2017-01-12 | 4,687 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2017-01-10 | 2017-01-12 | 6,250 | — | $0 | 6,250 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2017-01-10 | 2017-01-12 | 9,375 | — | $0 | 18,750 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2017-01-10 | 2017-01-12 | 2,500 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2017-01-10 | 2017-01-12 | 20,312 | — | $0 | 149,740 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2017-01-10 | 2017-01-12 | 10,312 | — | $0 | 84,055 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | F Tax w/h | 2017-01-10 | 2017-01-12 | 9,690 | $0.63 | $6.1K | 140,050 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2016-06-13 | 2016-06-15 | 5,000 | — | $0 | 10,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2016-06-13 | 2016-06-15 | 9,375 | — | $0 | 18,750 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | S Sale | 2016-06-13 | 2016-06-15 | 4,856 | $1.03 | $5.0K | 129,428 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2016-06-13 | 2016-06-15 | 5,000 | — | $0 | 73,743 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2016-06-13 | 2016-06-15 | 9,375 | — | $0 | 134,284 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | S Sale | 2016-03-15 | 2016-03-16 | 12,033 | $0.83 | $10.0K | 124,909 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2016-03-14 | 2016-03-16 | 300,000 | — | $0 | 300,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2016-03-14 | 2016-03-16 | 135,000 | — | $0 | 135,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2016-03-14 | 2016-03-16 | 9,375 | — | $0 | 28,125 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2016-03-14 | 2016-03-16 | 6,250 | — | $0 | 12,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2016-03-14 | 2016-03-16 | 4,687 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2016-03-14 | 2016-03-16 | 4,688 | — | $0 | 4,687 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2016-03-14 | 2016-03-16 | 25,000 | — | $0 | 136,942 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2015-06-12 | 2015-06-16 | 9,375 | — | $0 | 28,125 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2015-06-12 | 2015-06-16 | 9,375 | — | $0 | 116,513 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | S Sale | 2015-06-12 | 2015-06-16 | 4,571 | $2.69 | $12.3K | 111,942 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | S Sale | 2015-05-20 | 2015-05-21 | 7,543 | $1.88 | $14.2K | 107,138 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2015-05-19 | 2015-05-21 | 6,250 | — | $0 | 18,750 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2015-05-19 | 2015-05-21 | 75,000 | — | $0 | 75,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2015-05-19 | 2015-05-21 | 37,500 | — | $0 | 37,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2015-05-19 | 2015-05-21 | 4,687 | — | $0 | 9,375 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2015-05-19 | 2015-05-21 | 4,687 | — | $0 | 4,687 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2015-05-19 | 2015-05-21 | 15,624 | — | $0 | 114,681 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | F Tax w/h | 2015-01-30 | 2015-01-30 | 9,206 | $2.11 | $19.4K | 99,057 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2015-01-27 | 2015-01-30 | 20,100 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2015-01-27 | 2015-01-30 | 20,100 | — | $0 | 108,263 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | F Tax w/h | 2014-09-19 | 2014-09-19 | 3,401 | $3.06 | $10.4K | 88,163 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2014-09-17 | 2014-09-19 | 7,425 | — | $0 | 20,100 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2014-09-17 | 2014-09-19 | 7,425 | — | $0 | 91,564 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | S Sale | 2014-08-13 | 2014-08-14 | 18,341 | $3.17 | $58.1K | 84,139 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2014-08-12 | 2014-08-14 | 37,500 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2014-08-12 | 2014-08-14 | 37,500 | — | $0 | 102,480 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2014-06-12 | 2014-06-16 | 37,500 | — | $0 | 37,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2014-06-12 | 2014-06-16 | 37,500 | — | $0 | 37,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | S Sale | 2014-03-17 | 2014-03-18 | 4,634 | $12.25 | $56.8K | 64,980 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2014-03-14 | 2014-03-18 | 4,688 | — | $0 | 9,374 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2014-03-14 | 2014-03-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2014-03-14 | 2014-03-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2014-03-14 | 2014-03-18 | 4,688 | — | $0 | 14,062 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2014-03-14 | 2014-03-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2014-03-14 | 2014-03-18 | 9,376 | — | $0 | 69,614 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | S Sale | 2013-08-19 | 2013-10-07 | 3,112 | $8.68 | $27.0K | 60,238 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2013-08-13 | 2013-08-15 | 6,562 | — | $0 | 16,250 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | F Tax w/h | 2013-08-13 | 2013-08-15 | 2,951 | — | $0 | 60,399 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2013-08-13 | 2013-08-15 | 6,562 | — | $0 | 63,350 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | S Sale | 2013-03-12 | 2013-10-07 | 2,134 | $11.90 | $25.4K | 56,788 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2013-03-12 | 2013-03-14 | 37,500 | — | $0 | 37,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2013-03-12 | 2013-03-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2013-03-12 | 2013-03-14 | 18,750 | — | $0 | 18,750 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2013-03-12 | 2013-03-14 | 4,688 | — | $0 | 14,062 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2013-03-12 | 2013-03-14 | 4,688 | — | $0 | 58,922 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | F Tax w/h | 2013-03-12 | 2013-03-14 | 2,134 | — | $0 | 56,788 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2012-08-07 | 2012-08-07 | 7,000 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2012-08-07 | 2012-08-07 | 7,000 | $4.11 | $28.8K | 54,234 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2012-07-30 | 2012-08-01 | 34,167 | — | $0 | 7,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2012-07-30 | 2012-08-01 | 34,167 | $4.11 | $140.4K | 47,234 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2012-05-08 | 2012-05-10 | 25,000 | — | $0 | 25,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2012-05-08 | 2012-05-10 | 18,750 | — | $0 | 18,750 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2012-05-08 | 2012-05-10 | 37,500 | — | $0 | 37,500 | SEC↗ |